CD2 (LFA-2) is expressed on thymocytes, natural killer cells, and virtually all peripheral T cells. CD2 binds to its primary ligand CD58 (LFA-3) on antigen presenting cells (APC) and stabilizes the T cell-APC interaction; this stable interaction then optimizes Ag-specific T-cell activation. We assessed whether CD2-cross-linking by mAb augments the process of T-cell stimulation through the TCR/CD3 complex. Plate-bound anti-CD2 or anti-CD3 mAb alone had no measurable effect on any of the assessed activation parameters of resting T cells. However, concomitant signaling through both CD2 and CD3 by plate-bound antibodies resulted in marked increases in CD69 expression on the T-cell surface and T-cell-cellular metabolism, as assessed by the ability of the cell to reduce 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxylmethoxyphenyl)-2-(4-sulphophenyl)-2H-tetrazolium (MTS) to formazan. In addition, simultaneous cross-linking of CD2 and CD3 caused a significant (P<0.001) increase in phosphatidylinositol hydrolysis in resting T cells compared to stimulation with anti-CD3 mAb alone and anti-CD3 mAb plus anti-CD2 isotype control antibody. These results indicate that CD2 augments signaling through CD3, and consequently functions as a costimulatory molecule for resting T cells in the initial activation step.
KamounM, MartinPJ, HansenJA, BrownMA, SiadakAW, NowinskiRC.Identification of a human T lymphocyte surface protein associated with the E-rosette receptor. J Exp Med1981;153:207–212.
2.
BernardA, GelinC, RaynalB, PhamD, GosseC, BoumsellL.Phenomenon of human T cells rosetting with sheep erythrocytes analyzed with monoclonal antibodies. “Modulation” of a partially hidden epitope determining the conditions of interaction between T cells and erythrocytes. J Exp Med1982;155:1317–1333.
3.
BarclayAN, BrownMH, LawSKA, McKnightAJ, TomlinsonMG, van der MerwePA.The leukocyte antigen facts book. 2nd ed.San Diego: Academic Press; 1997: 1–613.
4.
PlunkettML, SandersME, SelvarajP, DustinML, SpringerTA.Rosetting of activated human T lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD2 and lymphocyte function-associated antigen 3 (LFA-3). J Exp Med1987; 165:664–676.
BiererBE, PetersonA, GorgaJC, HerrmannSH, BurakoffSJ.Synergistic T cell activation via the physiological ligands for CD2 and the T cell receptor. J Exp Med1988;168:1145–1156.
7.
KoyasuS, LawtonT, NovickD, RecnyMA, SilicianoRF, WallnerBP, ReinherzEL.Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen. Proc Natl Acad Sci USA1990;87:2603–2607.
CooperPH, HawthorneJM.Phosphatidylinositol kinase and diphosphoinositide kinase of rat kidney cortex properties and subcellular localization. Biochem J1976;160:97–105.
21.
ImbodenJB, WeissA.The T-cell antigen receptor regulates sustained increases in cytoplasmic free Caβ+ through extracellular Caβ+ influx and ongoing intracellular Ca2+ mobilization. Biochem J1987;247: 695–700.
22.
MangerB, WeissA, ImbodenJ, LaingT, StoboJD.The role of protein kinase C In transmembrane signaling by the T cell antigen receptor complex effects of stimulation with soluble or immobilized CD3 antibodies. J Immunol1987;139:2755–2760.
23.
FarrarWL, RuscettiFW.Association of protein kinase C activation with IL 2 receptor expression. J Immunol1986;136:1266–1273.
24.
TestiR, D'AmbrosioD, De MariaR, SantoniA.The CD69 receptor: a multipurpose cell-surface trigger for hematopoietic cells. Immunol Today1994;15:479–483.
25.
BerneySM, AtkinsonTP.Phosphatidylinositol hydrolysis in freshly isolated human lymphocytes. J Immunol Methods1995;186: 71–77.0
MosmannT.Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods1983;65:55–63.
28.
AtkinsonTP, KalinerMA, HohmanRJ.Phospholipase C-Gammal is translocated to the membrane of rat basophilic leukemia cells in response to aggregation of IgE receptors. J Immunol1992;148: 2194–2200.
29.
ShimizuY, van SeventerGA, HorganKJ, ShawS.Costimulation of proliferative responses of resting CD4+ T cells by the interaction of VLA-4 and VLA-5 with fibronectin or VLA-6 with laminin. J Immunol1990;145:59–67.
30.
WardSG, LeySC, MacPheeC, CantrellDA.Regulation of D-3 phosphoinosities during T cell activation via the T cell antigen receptor/ CD3 complex and CD2 antigens. Eur J Immunol1992;22:45–49.
31.
FriedrichB, CantrellDA, GullbergM.Evidences for protein kinase C. Activation in T lymphocytes by stimulation of either the CD2 or CD3 antigens. Eur J Immunol1989;19:17–23.
32.
PantaleoG, OliveD, PoggiA, KozumboWJ, MorettaL, MorettaA.Transmembrane signaling via the T11-dependent pathway of human T cell activation. Evidence for the involvement of 1,2-diacylglycerol and inositol phosphates. Eur J Immunol1987;17:55–60.
33.
MoingeonPE, LucichJL, StebbinsCC, RecnyMA, WallnerBP, KoyasuS, ReinherzEL.Complementary roles for CD2 and LFA-1 adhesion pathways during T cell activation. Eur J Immunol1991;21: 605–610.
34.
MeuerSC, HusseyRE, FabbiM, FoxDA, AcutoO, FitzgeraldKA, HodgdonJC, ProtentisJP, SchlossmanSF, ReinherzEL.An alternative pathway of T-cell activation: a functional role for the 50 kd T11 sheep erythrocyte receptor protein. Cell1984;36:897–906.
35.
BreittmayerJB, DaleyJF, LevineHB, SchlossmanSF.The T11 (CD2) molecule is functionally linked to the T3/Ti T cell receptor in the majority of T cells. J Immunol1987;139:2899–2905.
36.
BiererBE, BarbosaJ, HerrmannS, BurakoffSJ.Interaction of CD2 with its ligand, LFA-3, in human T cell proliferation. J Immunol1988;140:3358–3363.
37.
KozarskyKF, TsaiC, BottCM, AlladaG, LiLL, FoxDA.An anti-CD2 monoclonal antibody that both inhibits and stimulates T cell activation recognizes a subregion of CD2 distinct from known ligandbinding sites. Cell Immunol1993;150:235–246.
38.
YangSY, ChouaibS, DupontB.A common pathway for T lymphocyte activation involving both the CD3-Ti complex and CD2 sheep erythrocyte receptor determinants. J Immunol1986;137: 1097–1100.
39.
SuthanthiranM.T-cell differentiation antigen cluster 2 (CD2) is a receptor for accessory cells and can generate and/or transduce accessory signals. Cell Immunol1988;112:112–122.
40.
SuthanthiranM.A novel model for antigen-dependent activation of normal human T cells. Transmembrane signaling by crosslinkage of the CD3/T cell receptor-a/ß complex with the cluster determinant 2 Antigen. J Exp Med1990;171:1965–1979.
41.
SehajpalPK, ZankerB, LiB, MurthiVK, SubramaniamA, SharmaVK, EstinD, SkolnikEY, WiederKJ, WalzG, FotinoM, StenzelKH, StromTB, SuthanthiranM.The molecular basis for the synergism between the CD3/aß T cell receptor and the CD2 antigen-derived signals in promoting T cell proliferation. Transplantation1991;51:468–474.
42.
ChangHC, MoingeonP, PedersenR, LucichJ, StebbinsC, ReinherzEL.Involvement of the PPPGHR motif in T cell activation via CD2. J Exp Med1990;172:351–355.
DanielianS, FagardR, AlcoverA, AcutoO, FischerS.The tyrosine kinase activity of p56lck is increased in human T cells activated via CD2. Eur J Immunol1991;21:1967–1970.
GuyotDJ, NewboundGC, LairmoreMD.Co-stimulation of human peripheral blood mononuclear cells with IL-2 and anti-CD3 monoclonal antibodies induces phosphorylation of CREB. Immunol Lett1998;61:45–52.
47.
KivensWJ, HuntISW, MobleyJL, ZellT, DellCL, BiererBE, ShimizuY.Identification of a proline-rich sequence in the CD2 cytoplasmic domain critical for regulation of integrin-mediated adhesion and activation of phosphoinositide 3-kinase. Mol Cell Biol1998;18: 5291–5307.
48.
ShimizuY, MobleyJL, FinkelsteinLD, ChanASH. A role for phosphatidylinositol 3-kinase in the regulation of ßl integrin activity by the CD2 antigen. J Cell Biol1995;131:1867–1880.
49.
KingPD, SadraA, HanA, LiuXP, Sunder-PlassmannR, ReinbergEL, DupeatB.CD2 signaling in T cells involves tyrosine phosphorylation and activation of the Tec family kinase, EMT/ITK/TSK. Int Immunol1996;8:1707–1714.
50.
HubertP, DebreP, BoumsellL, BismuthG.Tyrosine phosphorylation and association with phospholipase C(gamma)-1 of the GAP-associated 62-kD protein after CD2 stimulation of jurkat T cell. J Exp Med1993;178:1587–1596.
51.
UmeharaH, HuangJY, KonoT, TabassamFH, OkazakiT, GoudaS, NaganoY, BloomET, DomaeN.Co-stimulation of T cells with CD2 augments TCR-CD3-mediated activation of protein tyrosine kinase p72syk, resulting in increased tyrosine phosphorylation of adapter proteins, Shc and Cbl. Int Immunol1998;10:833–845.
52.
BoussiotisVA, FreemanGJ, GriffinJD, GrayGS, GribbenJG, NadlerLM.CD2 is involved in maintenance and reversal of human alloantigen-specific clonal anergy. J Exp Med1994;180:1665–1673.
53.
DeasO, DumontC, MacFarlaneM, RouleauM, HebibC, HarperF, HirschF, CharpentierB, CohenGM, SenikA.Caspase-independent cell death induced by anti-CD2 or staurosporine in activated human peripheral T lymphocytes. J Immunol1998;161:3375–3383.
54.
MollereauB, DeckertM, DeasO, Rieux-LaucatF, HirschF, BernardA, FischerA, LynchDH, CharpentierB, Le DeistF, SenikA.CD2-induced apoptosis in activated human peripheral T cells. A Fas-independent pathway that requires early protein tyrosine phosphorylation. J Immunol1996;156:3184–3190.
55.
MollereauB, BlanchardD, DeasO, DumontC, MetivierD, BernardA, McGrewJT, CharpentierB, VazquezA SenikA. Relationship between proliferation and susceptibility to CD95- and CD2-mediated apoptosis in stimulated primary T lymphocytes T cells manifesting proliferative unresponsiveness are preferentially susceptible to CD95-mediated apoptosis. J Immunol1997;159:2668–2677.
56.
HiraharaH, TsuchidaM, WatanabeT, HagaM, MatsumotoY, AboT, EguchiS.Long-term survival of cardiac allografts in rats treated before and after surgery with monoclonal antibody to CD2. Transplantation1995;59:85–90.
57.
Cavazzana-CalvoM, BordigoniP, MichelG.A phase II trial of partially incompatible bone marrow transplantation for high-risk acute lymphoblastic leukaemia in children: prevention of graft rejection with anti-LFA-1 and anti CD2 antibodies. Brit J Haematol1996;93:131–138.
